Mannkind (MNKD) FCF Margin Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 10,029.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 723.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,409.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,066.00 |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -309.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -309.00 |
| Dec 31, 2025 | 1,674.00 |
| Sep 30, 2025 | 11,266.00 |
| Jun 30, 2025 | 972,624.00 |
| Mar 31, 2025 | 18,577.00 |
| Dec 31, 2024 | 7,741.00 |
| Sep 30, 2024 | 11,016.00 |
| Jun 30, 2024 | 9,318.00 |
| Mar 31, 2024 | 8,621.00 |
| Dec 31, 2023 | 3,986.00 |
| Sep 30, 2023 | 14,888.00 |
| Jun 30, 2023 | 193,456.00 |
| Mar 31, 2023 | 6,615.00 |
| Dec 31, 2022 | 2,304.00 |
| Sep 30, 2022 | 726,888.00 |
| Jun 30, 2022 | 40,850.00 |
| Mar 31, 2022 | -12,632.00 |
| Dec 31, 2021 | -21,448.00 |
| Sep 30, 2021 | 22,016.00 |
| Jun 30, 2021 | 60,439.00 |
| Mar 31, 2021 | 54,621.00 |
| Dec 31, 2020 | 66,041.00 |
| Sep 30, 2020 | 105,131.00 |
| Jun 30, 2020 | -104,979.00 |
| Mar 31, 2020 | -35,202.00 |
| Dec 31, 2019 | 5,610.00 |
| Sep 30, 2019 | -733,779.00 |